These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33887734)

  • 21. Revealing the underlying mechanism of diabetic nephropathy viewed by microarray analysis.
    Qu W; Han C; Li M; Zhang J; Li L
    Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):353-9. PubMed ID: 25918880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weighted gene co-expression network analysis of key targets and interventional mechanism of Milkvetch root in diabetic nephropathy.
    Zeng SN; Li Y; Li YM; Wang SR
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9614-9627. PubMed ID: 37916327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of biomarkers and prediction of upstream miRNAs in diabetic nephropathy.
    Yin D; Guo Z; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1144331. PubMed ID: 36896170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functions of lumican and fibromodulin: lessons from knockout mice.
    Chakravarti S
    Glycoconj J; 2002; 19(4-5):287-93. PubMed ID: 12975607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of key lncRNAs contributing to diabetic nephropathy by gene co-expression network analysis.
    Shang J; Wang S; Jiang Y; Duan Y; Cheng G; Liu D; Xiao J; Zhao Z
    Sci Rep; 2019 Mar; 9(1):3328. PubMed ID: 30824724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of key genes in ruptured atherosclerotic plaques by weighted gene correlation network analysis.
    Xu BF; Liu R; Huang CX; He BS; Li GY; Sun HS; Feng ZP; Bao MH
    Sci Rep; 2020 Jul; 10(1):10847. PubMed ID: 32616722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic expression profiling and bioinformatics analysis on diabetic nephrology with ginsenoside Rg3.
    Wang J; Cui C; Fu L; Xiao Z; Xie N; Liu Y; Yu L; Wang H; Luo B
    Mol Med Rep; 2016 Aug; 14(2):1162-72. PubMed ID: 27279428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Validation of Prognostic Biomarkers Specifically Expressed in Macrophage in IgA Nephropathy Patients Based on Integrated Bioinformatics Analyses.
    Ding Y; Li H; Xu L; Wang Y; Yang H
    Front Mol Biosci; 2022; 9():884588. PubMed ID: 35601837
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of key pathways and genes in different types of chronic kidney disease based on WGCNA.
    Guo Y; Ma J; Xiao L; Fang J; Li G; Zhang L; Xu L; Lai X; Pan G; Chen Z
    Mol Med Rep; 2019 Sep; 20(3):2245-2257. PubMed ID: 31257514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular and scleral alterations in gene-targeted lumican-fibromodulin double-null mice.
    Chakravarti S; Paul J; Roberts L; Chervoneva I; Oldberg A; Birk DE
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2422-32. PubMed ID: 12766039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of miRNAs-genes regulatory network in diabetic nephropathy based on bioinformatics analysis.
    Yang F; Cui Z; Deng H; Wang Y; Chen Y; Li H; Yuan L
    Medicine (Baltimore); 2019 Jul; 98(27):e16225. PubMed ID: 31277135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Susceptibility Modules and Genes for Cardiovascular Disease in Diabetic Patients Using WGCNA Analysis.
    Liang W; Sun F; Zhao Y; Shan L; Lou H
    J Diabetes Res; 2020; 2020():4178639. PubMed ID: 32455133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and validation of immune and oxidative stress-related diagnostic markers for diabetic nephropathy by WGCNA and machine learning.
    Xu M; Zhou H; Hu P; Pan Y; Wang S; Liu L; Liu X
    Front Immunol; 2023; 14():1084531. PubMed ID: 36911691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of Complement Pathways in Kidney Tissue May Mediate Tubulointerstitial Injury in Diabetic Nephropathy.
    Jiang S; Jiao Y; Zou G; Gao H; Zhuo L; Li W
    Front Med (Lausanne); 2022; 9():845679. PubMed ID: 35479942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of the Key Genes and Signalling Pathways for Diabetic Nephropathy Using Bioinformatics Analysis.
    Li Z; Feng J; Zhong J; Lu M; Gao X; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():864407. PubMed ID: 35923621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening and Identification of Differentially Expressed Genes Between Diabetic Nephropathy Glomerular and Normal Glomerular via Bioinformatics Technology.
    Du J; Yang J; Meng L
    Comb Chem High Throughput Screen; 2021; 24(5):645-655. PubMed ID: 32954999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients.
    Chang Y; He J; Xiang X; Li H
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101435. PubMed ID: 32386798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8+T Cell-Related Gene Biomarkers in Macular Edema of Diabetic Retinopathy.
    Huang J; Zhou Q
    Front Endocrinol (Lausanne); 2022; 13():907396. PubMed ID: 35937822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy.
    Chen S; Chen L; Jiang H
    Dis Markers; 2022; 2022():9204201. PubMed ID: 35637650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiling in glomeruli of diabetic nephropathy rat.
    Zhang Q; Xiao X; Li M; Li W; Yu M; Zhang H; Sun X; Mao L; Xiang H
    Exp Biol Med (Maywood); 2012 Aug; 237(8):903-11. PubMed ID: 22903132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.